Nozawa, K.
Terada, M.
Onishi, M.
Ozaki, Y.
Takano, T.
Fakhouri, W.
Novick, D.
Haro, J. M.
Faris, L. H.
Kawaguchi, T.
Tanizawa, Y.
Tsurutani, Junji http://orcid.org/0000-0002-6260-6943
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 13 January 2023
Accepted: 8 April 2023
First Online: 22 May 2023
Declarations
:
: Kazuki Nozawa, Mitsou Terada, Mai Onishi and Yukinori Ozaki declare no conflict of interest. Toshimi Takano has received Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Chugai, Daiichi-Sankayo, Eisai, Celtrion Healthcare, and Eli Lilly and Company. Walid Fakhouri, Diego Novak, Tsutomu Kawaguchi, and Yoshinori Tanizawa are employees of, and shareholders in, Eli Lilly and Company Ltd. Josep Maria Haro and Lydia Hanaa Faris are employees of Fundació Sant Joan de Déu, Universitat de Barcelona, who conducted the field work for this research under contract to Eli Lilly and Company Ltd.
: This study was approved by the ethics committee in each participating site and all investigators complied with the Declaration of Helsinki in the conduct of the research.
: For this type of study, formal consent is not required.
: Not applicable.